Mahad Fire Incident: Cops Arrest Maintenance Head Of Pharma Company

Navi Mumbai: Nearly seven days after a massive fire broke out at a chemical plant in Raigad district, the Mahad MIDC police on Friday arrested the maintenance head of the Sanpada-based pharma company Blue Jet Healthcare that owned the plant.

The fire had erupted after an explosion in the chemical plant of Blue Jet Healthcare at Mahad MIDC around 10.30am on November 3. Seven workers suffered injuries and were hospitalised, while 11 workers were reported missing. The fire was doused by fire brigade personnel around 5pm, but the administration had to summon the National Disaster Response Force (NDRF) unit in Pune to carry out search and rescue operations owing to heat and the presence of chemicals inside the plant.

The NDRF team extricated 11 bodies in badly charred condition. They bodies were handed over to the families of the deceased after DNA sampling at Panvel rural hospital. Three of them belonged to other states and were identified as Abhimanyu Urao, and Jeevan Kumar Chaubey from Bokaro, Jharkhand, and Vikas Mahanto from Purulia, West Bengal. Eight others were from Maharashtra and were identified as Sanjay Pawar from Kharavli, Mahad; Akshay Sutar from Taliye, Mahad; Aditya More from Chochinde, Mahad; Shashikant Bhusaane from Nilanga, Latur; Somnath Waydande from Koregaon, Satara; Vishal Koli from Shirpur, Dhule; Aslam Shaikh from Karad, Satara; and Satish Salunke from Mahad.

On November 7, Mahad MIDC lodged an FIR under sections 304 (Punishment for culpable homicide not amounting to murder), 308 (attempt to commit culpable homicide), 285 (negligent conduct with respect to fire or combustible mat­ter), 286 (negligent conduct with respect to explosive substance) and 34 (common intention) of the Indian Penal Code. Shailesh Joshi, the maintenance head of Blue Jet Healthcare was arrested under these charges on Friday, said police.

Related Posts

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

New Delhi: AstraZeneca’s India-arm has partnered with National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, to build clinical research capabilities at 25 emerging geographies in a bid to extend…

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into papillary-only non-muscle-invasive bladder cancer (NMIBC). Wednesday’s approval comes nearly three months ahead…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction